{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:23:54Z","timestamp":1779909834844,"version":"3.53.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:00:00Z","timestamp":1470355200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.055","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T18:25:39Z","timestamp":1470421539000},"page":"4520-4525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4 + T cells but no increase in avidity for Ag85A"],"prefix":"10.1016","volume":"34","author":[{"given":"Hannah J.","family":"Metcalfe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Connelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ivan","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vordermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Villarreal-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2016.07.055_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tvjl.2004.11.001","article-title":"Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle","volume":"171","author":"Vordermeier","year":"2006","journal-title":"Vet J"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.055_b0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/vr.102581","article-title":"Vaccination against tuberculosis in badgers and cattle: an overview of the challenges, developments and current research priorities in Great Britain","volume":"175","author":"Chambers","year":"2014","journal-title":"Vet Rec"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.055_b0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/vr.100969","article-title":"Bovine tuberculosis trends in the UK and the Republic of Ireland, 1995\u20132010","volume":"172","author":"Abernethy","year":"2013","journal-title":"Vet Rec"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.07.055_b0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.vetmic.2014.08.013","article-title":"Bovine tuberculosis surveillance in cattle and free-ranging wildlife in EU Member States in 2013: a survey-based review","volume":"173","author":"Riviere","year":"2014","journal-title":"Vet Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.07.055_b0025","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/gcb.12942","article-title":"Avoiding verisimilitude when modelling ecological responses to climate change: the influence of weather conditions on trapping efficiency in European badgers (Meles meles)","volume":"21","author":"Noonan","year":"2015","journal-title":"Glob Change Biol"},{"key":"10.1016\/j.vaccine.2016.07.055_b0030","unstructured":"Krebs JR, Anderson R, Clutton-Brock T, Morrison I, Young D, Donnelly C. Bovine tuberculosis in cattle and badgers \u2013 report to the Rt Hon Dr. Jack Cunningham MP. The Ministry of Agriculture FaF; 1997."},{"issue":"11","key":"10.1016\/j.vaccine.2016.07.055_b0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0966-842X(00)88994-5","article-title":"Animal models of protective immunity in tuberculosis to evaluate candidate vaccines","volume":"3","author":"Griffin","year":"1995","journal-title":"Trends Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.055_b0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infectious Diseases"},{"issue":"16","key":"10.1016\/j.vaccine.2016.07.055_b0045","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.vaccine.2012.02.018","article-title":"Bovine tuberculosis vaccine research: historical perspectives and recent advances","volume":"30","author":"Waters","year":"2012","journal-title":"Vaccine"},{"issue":"1579","key":"10.1016\/j.vaccine.2016.07.055_b0050","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","article-title":"Tuberculosis vaccines: beyond bacille Calmette-Guerin","volume":"366","author":"McShane","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"36","key":"10.1016\/j.vaccine.2016.07.055_b0055","doi-asserted-by":"crossref","first-page":"25041","DOI":"10.1074\/jbc.M114.581579","article-title":"The three mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions","volume":"289","author":"Backus","year":"2014","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.055_b0060","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1371\/journal.pntd.0000199","article-title":"Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting","volume":"2","author":"Tanghe","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.07.055_b0065","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1074\/jbc.M112.415679","article-title":"Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex","volume":"288","author":"Kuo","year":"2013","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.vaccine.2016.07.055_b0070","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.07.055_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","author":"Stylianou","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.055_b0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0008-8749(84)90082-0","article-title":"Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin","volume":"84","author":"Orme","year":"1984","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.055_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00190265","article-title":"In vivo depletion of CD4 and CD8 T lymphocytes impairs Mycobacterium w vaccine-induced protection against M. tuberculosis in mice","volume":"182","author":"Guleria","year":"1993","journal-title":"Med Microbiol Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2016.07.055_b0090","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.07.055_b0095","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2016.07.055_b0100","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20090504","article-title":"Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells","volume":"206","author":"Geiger","year":"2009","journal-title":"J Exp Med"},{"issue":"50","key":"10.1016\/j.vaccine.2016.07.055_b0105","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1016\/j.vaccine.2007.10.011","article-title":"Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity","volume":"25","author":"Endsley","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.055_b0110","series-title":"Limiting dilution analysis of cells in the immune system","author":"Lefkovits IaW","year":"1979"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.055_b0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.immuni.2013.11.017","article-title":"Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues","volume":"40","author":"Honda","year":"2014","journal-title":"Immunity"},{"issue":"47","key":"10.1016\/j.vaccine.2016.07.055_b0120","doi-asserted-by":"crossref","first-page":"20453","DOI":"10.1073\/pnas.1008437107","article-title":"Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery","volume":"107","author":"Han","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.055_b0125","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1-IL-2-secreting central memory cells","volume":"190","author":"Lindenstrom","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.055_b0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2012.02.008","article-title":"A mouse model of tuberculosis reinfection","volume":"92","author":"Henao-Tamayo","year":"2012","journal-title":"Tuberculosis"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.055_b0135","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.4049\/jimmunol.174.9.5433","article-title":"Modulation of memory CD4 T cell function and survival potential by altering the strength of the recall stimulus","volume":"174","author":"Patke","year":"2005","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.07.055_b0140","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.1001867","article-title":"Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigens","volume":"185","author":"Caserta","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.055_b0145","doi-asserted-by":"crossref","first-page":"e1005490","DOI":"10.1371\/journal.ppat.1005490","article-title":"TIM3 mediates T cell exhaustion during Mycobacterium tuberculosis infection","volume":"12","author":"Jayaraman","year":"2016","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.055_b0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ni.3386","article-title":"Control of T cell antigen reactivity via programmed TCR downregulation","volume":"17","author":"Gallegos","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.07.055_b0155","doi-asserted-by":"crossref","first-page":"872710","DOI":"10.5402\/2012\/872710","article-title":"The major histocompatibility complex in bovines: a review","volume":"2012","author":"Behl","year":"2012","journal-title":"ISRN Vet Sci"},{"key":"10.1016\/j.vaccine.2016.07.055_b0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2014.00321","article-title":"The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis","volume":"5","author":"Huygen","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.07.055_b0165","unstructured":"UniProtKB - P0C2T1 (A85A_MYCBO). Universal Protein Resource (UniProt); 2007 [cited 2015]. Diacylglycerol acyltransferase\/mycolyltransferase Ag85A protein sequence from Mycobacterium bovis (strain ATCC BAA-935\/AF2122\/97)]. <http:\/\/www.uniprot.org\/uniprot\/P0C2T1>."},{"key":"10.1016\/j.vaccine.2016.07.055_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2015.10.008","article-title":"M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens","author":"Coscolla","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.vaccine.2016.07.055_b0175","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.vaccine.2011.12.044","article-title":"In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCG","volume":"30","author":"Venkataswamy","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.055_b0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.it.2015.12.009","article-title":"Reprogramming the T cell response to tuberculosis","volume":"37","author":"Woodworth","year":"2016","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.055_b0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the TB-infected lung","volume":"16","author":"Orme","year":"2015","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.07.055_b0190","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.1300283","article-title":"Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation","volume":"192","author":"Woodworth","year":"2014","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2016.07.055_b0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.it.2014.04.006","article-title":"Tuberculosis vaccines\u2013rethinking the current paradigm","volume":"35","author":"Andersen","year":"2014","journal-title":"Trends Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T11:54:38Z","timestamp":1536494078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":39,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16306533"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4+ T cells but no increase in avidity for Ag85A","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}